Product Code: SR1020G237_Report
The global liquid dietary supplements market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 8% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Liquid dietary supplements are consumed to increase the nutritional intake, reduce the risk of chronic diseases, promote long-term health and improve the overall quality of life. These supplements are generally available at fitness centers and drug stores, grocery stores, and health food stores in different forms, including soft gels, capsules, tablets, liquid, powders, and gummies. At present, their demand is escalating across the globe on account of the rising consumer inclination towards functional consumables, which are manufactured using natural ingredients.
Liquid Dietary Supplements Market Trends:
The growing prevalence of undernutrition, especially in children and the geriatric population, represents one of the major factors influencing the market growth. Special liquid dietary supplements with extra calories or protein are widely available to satisfy the specific nutritional needs of individuals. Apart from this, several manufacturers are offering liquid dietary supplements for patients receiving dialysis treatments to expand their product portfolio and existing consumer base. Moreover, they are offering products for tube feeding via online distribution channels, which is contributing to market growth. Liquid dietary supplements are also gaining traction as a convenient alternative to solid dosage forms, such as tablets and capsules, for children or individuals with sensitive or irritable digestive systems. These supplements have a pleasant taste and can be added to drinks and food products like juices and cereals. Furthermore, the increasing number of chronic illnesses and the growing health consciousness among individuals are other factors anticipated to bolster the growth of the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global liquid dietary supplements market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, ingredient, application and distribution channel.
Breakup by Ingredient:
- Vitamins and Minerals
- Botanical
- Proteins and Amino Acids
- Others
Breakup by Application:
- Bone and Joint Health
- Heart Health
- Immune Health
- Sports Nutrition
- Weight Loss
- Digestive Health
- Others
Breakup by Distribution Channel:
- Supermarkets and Hypermarkets
- Health and Beauty Retail Stores
- Drug Stores
- Online Stores
Breakup by Region:
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Amway (Alticor Global Holdings Inc), Arkopharma, BASF SE, Bayer AG, DuPont de Nemours Inc., Glanbia plc, GlaxoSmithKline plc and Koninklijke DSM.
Key Questions Answered in This Report:
- How has the global liquid dietary supplements market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global liquid dietary supplements market?
- What are the key regional markets?
- What is the breakup of the market based on the ingredient?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the distribution channel?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global liquid dietary supplements market and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Liquid Dietary Supplements Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Ingredient
- 6.1 Vitamins and Minerals
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Botanical
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Proteins and Amino Acids
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Others
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
7 Market Breakup by Application
- 7.1 Bone and Joint Health
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Heart Health
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Immune Health
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Sports Nutrition
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Weight Loss
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
- 7.6 Digestive Health
- 7.6.1 Market Trends
- 7.6.2 Market Forecast
- 7.7 Others
- 7.7.1 Market Trends
- 7.7.2 Market Forecast
8 Market Breakup by Distribution Channel
- 8.1 Supermarkets and Hypermarkets
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Health and Beauty Retail Stores
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Drug Stores
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Online Stores
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Abbott Laboratories
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.1.4 SWOT Analysis
- 14.3.2 Amway (Alticor Global Holdings Inc)
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.3 Arkopharma
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.4 BASF SE
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.4.4 SWOT Analysis
- 14.3.5 Bayer AG
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.5.4 SWOT Analysis
- 14.3.6 DuPont de Nemours Inc.
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.6.4 SWOT Analysis
- 14.3.7 Glanbia plc
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 Financials
- 14.3.8 GlaxoSmithKline plc
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.8.4 SWOT Analysis
- 14.3.9 Koninklijke DSM
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.9.4 SWOT Analysis